Alzheimer's Advances Show Need for Better Drugs

Associated Press + More

"It's kind of like finding high cholesterol" but not having drugs that can lower it, said Dr. Mark Sager, director of the Wisconsin Alzheimer's Institute at the University of Wisconsin-Madison. He was involved in a study of a different Alzheimer's-linked gene that will be reported this week.

Scientists also don't know if the plaque is a cause, an effect, or just a sign of Alzheimer's. Two experimental drugs seemed to clear plaque but did not lead to clinical improvement.

"We've still got a long way to go," Sager said.


 Follow U.S. News Science on Twitter.